13 Dead In India’s Nipah Outbreak; CEPI Announces $25M Over 5 Years For Vaccine Development

CIDRAP News: Nipah death toll in India hits 12 as CEPI funds vaccine efforts
“…[Thursday] the Coalition for Epidemic Preparedness Innovations (CEPI) announced a $25 million collaboration with two pharmaceutical companies to develop a vaccine against the disease, one of the group’s priority diseases…” (Schnirring, 5/24).

Quartz: The latest outbreak of a deadly virus has scientists racing to create a vaccine
“…CEPI said it would grant up to $25 million over the next five years to U.S. pharma firms Profectus BioSciences and Emergent BioSolutions to advance the development of a vaccine against the viral infection, which has proved to be fatal in 70 percent of cases…” (Thomas, 5/25).

Reuters: India steps up hunt for origin of mysterious brain-damaging virus
“India began a fresh round of tests to trace the origin of a rare brain-damaging virus that has killed 13 people, a health official said on Monday, as initial tests on animals suspected of carrying the Nipah virus showed no sign of the disease…” (Patnaik/Jose, 5/28).